Furthermore, EZH2 inhibitors could prevent the negative effects of EZH2 overexpression on NK cells, thereby enhancing NK cell activation and differentiation and restoring their cytolytic activity to enhance anti-tumor immunity [109,124]. The gene discussed is EZH2; the disease is neoplasm.